Fintel reports that on February 10, 2025, D. Boral Capital downgraded their outlook for Annovis Bio (NYSE:ANVS) from Buy to Hold. Analyst Price Forecast Suggests 1,107.35% Upside As of January 28, ...

HANOI: The domestic stock market is set to witness a major event, with Becamex IDC preparing for a substantial stock auction ...